News

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...
University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.
Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.
Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...